July 14, 2025
  • HOME
  • NEWS
  • POLITICS
  • ECONOMY
  • SPORTS
  • PEOPLE
  • PRESS RELEASES
  • HOME
  • NEWS
  • POLITICS
  • ECONOMY
  • SPORTS
  • PEOPLE
  • PRESS RELEASES
International Diplomacy International Diplomacy
top
Ad Here: x
International Diplomacy
  • HOME
  • NEWS
  • POLITICS
  • ECONOMY
  • SPORTS
  • PEOPLE
  • PRESS RELEASES
Menu
  • HOME
  • NEWS
  • POLITICS
  • ECONOMY
  • SPORTS
  • PEOPLE
  • PRESS RELEASES
loading...
Latest Articles
  • President Donald Trump: A Historic Victory. A Dawn of Promising Saudi-American Relations
  • Donald Trump’s Victory and Its Promising Implications for the U.S. Economy and Global Peace
  • UN Security Council Stalls on Gaza Crisis Resolution
  • China Mourns the Sudden Passing of Former Premier Li Keqiang at 68
  • South Asian Nations React to Escalation in Israeli-Palestinian Conflict
  • Canadian Prime Minister Trudeau Faces Diplomatic Challenges and Travel Disruption During G20 Visit to India
  • G20 Summit 2023: African Union Gets Permanent Membership
  • Former Vice President Mike Pence Expresses Support for Potential Impeachment Inquiry into President Biden’s Foreign Business Dealings
  • THE REMARKABLE HAJJ INITIATIVES: A SOURCE O PRIDE
  • INTO A KING’S MIND
Home Oxford-AstraZeneca
UK to offer under-40s alternative to AstraZeneca Covid-19 vaccine given rare blood clot concerns

UK to offer under-40s alternative to AstraZeneca Covid-19 vaccine given rare blood clot concerns

Posted By: Editorial Teamon: May 07, 2021In: NEWSNo Comments

People under the age of 40 in the U.K. are to be offered an alternative to the Oxford-AstraZeneca Covid-19 vaccine, as concerns over links to rare blood clots continue to weigh on its roll out. Speaking at a press conference on Friday, Professor Wei Shen Lim, chair of the U.K.’s Joint Committee on Vaccination and […] Read more

Share 0
Tweet
Share
Share
Share
UK expected to approve Oxford-AstraZeneca Covid vaccine this week

UK expected to approve Oxford-AstraZeneca Covid vaccine this week

Posted By: Editorial Teamon: December 28, 2020In: NEWSNo Comments

LONDON — The coronavirus vaccine being developed by AstraZeneca and the University of Oxford is expected to be approved for use in the U.K. in coming days. The Financial Times reported Sunday that government officials confirmed that the Medicines and Healthcare products Regulatory Agency would imminently approve the vaccine, saying the announcement could come as soon as Tuesday. The […] Read more

Share 0
Tweet
Share
Share
Share

Advertising

Ad Here: x
Ad Here: x
top
vrp

2018 Powered By GroupW

  • HOME
  • NEWS
  • POLITICS
  • ECONOMY
  • SPORTS
  • PEOPLE
  • PRESS RELEASES